Sarepta Therapeutics Pre-Tax Profit Margin 2010-2024 | SRPT

Sarepta Therapeutics pre-tax profit margin for the quarter ending June 30, 2024 was 4.12%.

  • Sarepta Therapeutics average pre-tax profit margin for 2023 was -75.66%, a 15.6% decline from 2022.
  • Sarepta Therapeutics average pre-tax profit margin for 2022 was -65.45%, a 27.87% increase from 2021.
  • Sarepta Therapeutics average pre-tax profit margin for 2021 was -90.74%, a 27.56% decline from 2020.

Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.

Sarepta Therapeutics Pre-Tax Profit Margin 2010-2024 | SRPT

  • Sarepta Therapeutics average pre-tax profit margin for 2023 was -75.66%, a 15.6% decline from 2022.
  • Sarepta Therapeutics average pre-tax profit margin for 2022 was -65.45%, a 27.87% increase from 2021.
  • Sarepta Therapeutics average pre-tax profit margin for 2021 was -90.74%, a 27.56% decline from 2020.

Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.